Bath & Body Works, Inc. $BBWI Holdings Increased by Champlain Investment Partners LLC

Key Points

• Champlain Investment Partners LLC increased its stake in Bath & Body Works by 28.5%, owning approximately 1.25 million shares valued at $38.05 million as of its latest SEC filing.
• Recent analysts' evaluations have raised the stock's price target, with Wells Fargo setting it at $44.00 and JPMorgan at $46.00, contributing to a consensus rating of "Moderate Buy" and a price target of $42.53.
• The company announced a quarterly dividend of $0.20 per share, to be paid on September 5th, representing an annualized yield of 2.5% against a payout ratio of 21.33%.

Champlain Investment Partners LLC raised its position in shares of Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 28.5% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund owned 1,254,956 shares of the company's stock after buying an additional 278,612 shares during the quarter. Champlain Investment Partners LLC owned about 0.59% of Bath & Body Works worth $38,050,000 at the end of the most recent reporting period.

A number of other large investors have also modified their holdings of the business. Marshall Wace LLP purchased a new position in shares of Bath & Body Works in the fourth quarter worth about $628,000. Dimensional Fund Advisors LP increased its stake in Bath & Body Works by 17.1% during the 4th quarter. Dimensional Fund Advisors LP now owns 2,144,292 shares of the company's stock worth $83,135,000 after buying an additional 313,092 shares in the last quarter. MGO One Seven LLC purchased a new position in Bath & Body Works in the 4th quarter worth approximately $255,000. Voya Investment Management LLC grew its stake in shares of Bath & Body Works by 34.4% in the 4th quarter. Voya Investment Management LLC now owns 39,354 shares of the company's stock valued at $1,526,000 after buying an additional 10,080 shares during the period. Finally, Kovitz Investment Group Partners LLC purchased a new stake in shares of Bath & Body Works in the 4th quarter valued at approximately $258,000. Hedge funds and other institutional investors own 95.14% of the company's stock.

Bath & Body Works Price Performance

BBWI traded down $0.13 on Monday, reaching $29.23. The company's stock had a trading volume of 6,942,370 shares, compared to its average volume of 5,505,582. The stock has a market cap of $6.03 billion, a price-to-earnings ratio of 8.67, a price-to-earnings-growth ratio of 0.98 and a beta of 1.49. Bath & Body Works, Inc. has a 1 year low of $24.94 and a 1 year high of $41.87. The business's 50 day moving average is $30.63 and its 200 day moving average is $30.74.

Bath & Body Works (NYSE:BBWI - Get Free Report) last announced its quarterly earnings data on Thursday, August 28th. The company reported $0.37 earnings per share for the quarter, meeting the consensus estimate of $0.37. The firm had revenue of $1.55 billion during the quarter, compared to analyst estimates of $1.55 billion. Bath & Body Works had a negative return on equity of 48.43% and a net margin of 9.88%.Bath & Body Works's quarterly revenue was down .8% on a year-over-year basis. During the same period in the previous year, the company earned $0.37 earnings per share. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. As a group, research analysts forecast that Bath & Body Works, Inc. will post 3.3 earnings per share for the current fiscal year.

Bath & Body Works Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, September 5th. Shareholders of record on Friday, August 22nd will be issued a $0.20 dividend. The ex-dividend date of this dividend is Friday, August 22nd. This represents a $0.80 dividend on an annualized basis and a yield of 2.7%. Bath & Body Works's dividend payout ratio (DPR) is currently 23.74%.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on BBWI shares. JPMorgan Chase & Co. boosted their price target on shares of Bath & Body Works from $40.00 to $46.00 and gave the company an "overweight" rating in a research note on Monday, July 28th. Barclays raised their price target on Bath & Body Works from $30.00 to $32.00 and gave the stock an "equal weight" rating in a research note on Friday. Citigroup reduced their price objective on Bath & Body Works from $42.00 to $40.00 and set a "buy" rating for the company in a research note on Tuesday, August 19th. Telsey Advisory Group reaffirmed an "outperform" rating and issued a $38.00 price objective on shares of Bath & Body Works in a report on Thursday. Finally, Piper Sandler set a $39.00 target price on shares of Bath & Body Works and gave the company an "overweight" rating in a report on Thursday, May 15th. Twelve analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $41.62.

Bath & Body Works Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.